نتایج جستجو برای: brand names

تعداد نتایج: 76341  

2016
Akira Dobashi Kaori Kurata Mitsuhiro Okazaki Mari Nishizawa

PURPOSE Spontaneous inquiries about the development of adverse drug reactions (ADRs) to medicines can be extracted based on the questions posted by the general public on the electronic Japanese bulletin board "Yahoo! Japan Chiebukuro". Our aim was to clarify the characteristics related to people's descriptions of suspected ADRs and determine the reasons for submitting a spontaneous inquiry. M...

2013
Kurt Richard Brekke Tor Helge Holmås Odd Rune Straume

We study the impact of product margins on pharmacies’ incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies’ substitution incentives are determined by relative margins and relative patient copayments. Second, we exploit a un...

Journal: :Studies in health technology and informatics 2015
Pablo Carbonell Miguel Angel Mayer Àlex Bravo

Twitter has been proposed by several studies as a means to track public health trends such as influenza and Ebola outbreaks by analyzing user messages in order to measure different population features and interests. In this work we analyze the number and features of mentions on Twitter of drug brand names in order to explore the potential usefulness of the automated detection of drug side effec...

2014
Patrick Winter Paul Alpar Christian Geißler

Many companies place advertisements on search engine result pages, a practice referred to as search engine advertising (SEA). If their website also appears among the organic results, it is questionable whether SEA makes sense: Free clicks may be substituted by costly clicks on the advertisement (paid result). We propose a model that determines when paid results complement organic results and wh...

2015
Rachel M Taylor Jasjeet Mohain Faith Gibson Anita Solanki Jeremy Whelan Lorna A Fern

BACKGROUND Patient and public involvement (PPI) is central to research and service planning. Identifying effective, meaningful ways of involvement is challenging. The cohort study 'Do specialist services for teenagers and young adults with cancer add value?' follows young people for three years, examining outcomes associated with specialist care. Participant retention in longitudinal research c...

2006

Brand Names: Cardigox (Belgium); Cardiogoxin (Argentina); Cardioxin (India); Digacin (Germany); Digitek (US); Digomal (Italy); Digosin (Japan, Korea); Digoxina (Peru); Digoxine Navtivelle (France); Digoxin-Sandoz (Benin, Burkina-Faso, Ethiopia, Gambia, Ghana, Guinea, Ivory-Coast, Kenya, Liberia, Malawi, Mali, Mauritania, Mauritius, Morocco, Niger, Kuwait, Oman, Qutar, Saudi-Arabia, United-Arab-...

2009
KEVIN LEWIS Maxine Blount Mark Turnage

Intellectual property is every bit as important as physical property. For many corporations, intangible assets like brands and trademarks are even more valuable than tangible assets (Hopkins, 2003). For example, the Coca-Cola brand name is far more valuable than the ingredients that go into a can of Coca-Cola (Hopkins, 2003). Businesses expend a great deal of time, energy, and resources to prot...

2016

An older adult was admitted to hospital with a diagnosis of new-onset seizures. Admission orders included initiation of the anticonvulsant phenytoin (handwritten using the brand name Dilantin), 300 mg orally every evening. Before the pharmacy closed, a pharmacy staff member who was new to the clinical area entered the Dilantin order into the pharmacy computer system, so that the medication coul...

2007
KURT R. BREKKE ASTRID L. GRASDAL TOR HELGE HOLMÅS Kurt R. Brekke Astrid L. Grasdal

We study the relationship between regulatory regimes and pharmaceutical firms’ pricing strategies using a unique policy experiment from Norway, which in 2003 introduced a reference price (RP) system called “index pricing” for a sub-sample of off-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel dataset, cov...

پایان نامه :دانشگاه پیام نور استان بوشهر - دانشکده علوم انسانی 1389

با افزایش رقابت در حوزه کسب و کارها، شرکت ها به دنبال دستیابی به انواع جدیدی از دارایی ها افتادند که فاقد محدودیت های دارایی های موجود بوده و به سادگی قابل کپی برداری نباشد. جهت رسیدن به این هدف شرکت ها به دسته جدیدی از دارایی ها به نام دارایی های ناملموس توجه نمودند (نام و نشان تجاری) نام و نشان تجاری قوی ارائه دهنده ی اجزاء کلیدی مزیت رقابتی بوده و می تواند به عنوان منبع اصلی درآمدهای آتی شرک...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید